These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2037 related items for PubMed ID: 29955901

  • 21. Prokineticin 2 relieves hypoxia/reoxygenation-induced injury through activation of Akt/mTOR pathway in H9c2 cardiomyocytes.
    Su G, Sun G, Liu H, Shu L, Zhang W, Liang Z.
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):345-352. PubMed ID: 31899964
    [Abstract] [Full Text] [Related]

  • 22. The cystathionine γ-lyase/hydrogen sulfide pathway mediates the trimetazidine-induced protection of H9c2 cells against hypoxia/reoxygenation-induced apoptosis and oxidative stress.
    Zheng W, Liu C.
    Anatol J Cardiol; 2019 Sep; 22(3):102-111. PubMed ID: 31475956
    [Abstract] [Full Text] [Related]

  • 23. Danshensu alleviates cardiac ischaemia/reperfusion injury by inhibiting autophagy and apoptosis via activation of mTOR signalling.
    Fan G, Yu J, Asare PF, Wang L, Zhang H, Zhang B, Zhu Y, Gao X.
    J Cell Mol Med; 2016 Oct; 20(10):1908-19. PubMed ID: 27385290
    [Abstract] [Full Text] [Related]

  • 24. Exosomes Derived from Mesenchymal Stem Cells Rescue Myocardial Ischaemia/Reperfusion Injury by Inducing Cardiomyocyte Autophagy Via AMPK and Akt Pathways.
    Liu L, Jin X, Hu CF, Li R, Zhou Z, Shen CX.
    Cell Physiol Biochem; 2017 Oct; 43(1):52-68. PubMed ID: 28848091
    [Abstract] [Full Text] [Related]

  • 25. Platycodin D inhibits oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury.
    Wang Y, Che J, Zhao H, Tang J, Shi G.
    Biochem Biophys Res Commun; 2018 Sep 18; 503(4):3219-3224. PubMed ID: 30146261
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lycium barbarum polysaccharide protects rats and cardiomyocytes against ischemia/reperfusion injury via Nrf2 activation through autophagy inhibition.
    Pan H, Niu L, Wu Y, Chen L, Zhou X, Zhao Y.
    Mol Med Rep; 2021 Nov 18; 24(5):. PubMed ID: 34498711
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Heart protective effects and mechanism of quercetin preconditioning on anti-myocardial ischemia reperfusion (IR) injuries in rats.
    Liu H, Guo X, Chu Y, Lu S.
    Gene; 2014 Jul 15; 545(1):149-55. PubMed ID: 24769323
    [Abstract] [Full Text] [Related]

  • 31. Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injury.
    Li GH, Luo B, Lv YX, Zheng F, Wang L, Wei MX, Li XY, Zhang L, Wang JN, Chen SY, Tang JM, He X.
    J Transl Med; 2016 May 04; 14(1):116. PubMed ID: 27146579
    [Abstract] [Full Text] [Related]

  • 32. Shikonin protects H9C2 cardiomyocytes against hypoxia/reoxygenation injury through activation of PI3K/Akt signaling pathway.
    Wang S, Zhu Y, Qiu R.
    Biomed Pharmacother; 2018 Aug 04; 104():712-717. PubMed ID: 29807220
    [Abstract] [Full Text] [Related]

  • 33. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation.
    Yin Y, Guan Y, Duan J, Wei G, Zhu Y, Quan W, Guo C, Zhou D, Wang Y, Xi M, Wen A.
    Eur J Pharmacol; 2013 Jan 15; 699(1-3):219-26. PubMed ID: 23200898
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
    Kutala VK, Khan M, Mandal R, Ganesan LP, Tridandapani S, Kalai T, Hideg K, Kuppusamy P.
    J Pharmacol Exp Ther; 2006 Jun 15; 317(3):921-8. PubMed ID: 16467453
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Puerarin attenuates myocardial hypoxia/reoxygenation injury by inhibiting autophagy via the Akt signaling pathway.
    Tang H, Song X, Ling Y, Wang X, Yang P, Luo T, Chen A.
    Mol Med Rep; 2017 Jun 15; 15(6):3747-3754. PubMed ID: 28393209
    [Abstract] [Full Text] [Related]

  • 39. Knockdown of miR-665 Protects Against Cardiomyocyte Ischemia/Reperfusion Injury-Induced ROS Accumulation and Apoptosis Through the Activation of Pak1/Akt Signaling in Myocardial Infarction.
    Liu C, Tang M, Zhang X, Li J, Cao G.
    Int Heart J; 2020 Mar 28; 61(2):347-354. PubMed ID: 32132320
    [Abstract] [Full Text] [Related]

  • 40. Troxerutin attenuates oxygen‑glucose deprivation and reoxygenation‑induced oxidative stress and inflammation by enhancing the PI3K/AKT/HIF‑1α signaling pathway in H9C2 cardiomyocytes.
    Yu ZP, Yu HQ, Li J, Li C, Hua X, Sheng XS.
    Mol Med Rep; 2020 Aug 28; 22(2):1351-1361. PubMed ID: 32626962
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 102.